Skip to main content
. 2020 Mar 5;13(3):100107. doi: 10.1016/j.waojou.2020.100107

Table 1.

Demographic data.

Parameter Respondents (n = 883)
Country of residence, % (n/total) North America 18.9 (167)
Latin America 18.7 (165)
Europe 46.2 (408)
Africa/Middle-East 3.8 (34)
Asia-Pacific 12.4 (109)
Specialty, % (n/total) Allergy/Immunology 76.8 (674/877)
Dermatology 22.1 (194/877)
Pediatrics 10.7 (94/877)
Rheumatology 3.2 (28/877)
General practice 1.9 (17/877)
Other 3.9 (34/877)
>1 specialty indicated by the same respondent 16.3 (143/877)
Place of work, % (n/total) Private practice 47.7 (420/879)
University clinic 41.2 (362/879)
Hospital 36.8 (324/879)
Specialized urticaria centre 3.9 (35/879)
Other 2.9 (26/879)
>1 place of work indicated by the same respondent 24.8 (218/879)
Years of practice, median (IQR) 15 (7–26)
Number of patients with urticarial vasculitis seen per year, median (IQR) 5 (2–10)

IQR: interquartile range